Similarly, in vitro treatment of pre-B-ALL cells with BCR-ABL inhibitor GZD824 downregulates IRS-1 and the subsequent activation of the PI3K/AKT pathway, inducing cell cycle arrest and promoting apoptosis [126]. This evidence concerns the gene IRS1 and acute lymphoblastic leukemia.